ImmunityBio Inc
(NASDAQ: IBRX)

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

2.300

+0.100 (+4.55%)
Range 2.161 - 2.340   (8.28%)
Open 2.210
Previous Close 2.200
Bid Price 2.790
Bid Volume 32
Ask Price 2.820
Ask Volume 8
Volume 11,962,368
Value -
Remark
Delayed prices. Updated at 05 Dec 2025 05:00.
Data powered by
View All Events


Top Contributors

robinhan avatar
5699
Followers 2878
Posts 2827

Loading Chart...

Please login to view stock data and analysis